135 related articles for article (PubMed ID: 1654240)
1. Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant alpha-interferon for chronic non-A, non-B hepatitis.
Omata M; Ito Y; Yokosuka O; Imazeki F; Tagawa M; Takano S; Hosoda K; Tada M; Ohto M; Ito K
Dig Dis Sci; 1991 Sep; 36(9):1217-22. PubMed ID: 1654240
[TBL] [Abstract][Full Text] [Related]
2. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
Niederau C; Strohmeyer G; Heintges T; Peter K; Göpfert E
Hepatogastroenterology; 1998; 45(21):797-804. PubMed ID: 9684137
[TBL] [Abstract][Full Text] [Related]
3. Histologically advanced chronic hepatitis C treated with recombinant alpha-interferon: a randomized placebo-controlled double-blind cross-over study.
Sieck JO; Ellis ME; Alfurayh O; Ali MA; Ali HA; Ayub A; al-Fadda M; Zafar M; Halim M; Bernvil SS
J Hepatol; 1993 Nov; 19(3):418-23. PubMed ID: 7512110
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled trial of recombinant human alpha-interferon therapy for chronic non-A, non-B (type C) hepatitis.
Di Bisceglie AM; Martin P; Kassianides C; Lisker-Melman M; Goodman Z; Banks SM; Hoofnagle JH
J Hepatol; 1990; 11 Suppl 1():S36-42. PubMed ID: 2127786
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C. Comparison of alanine aminotransferase normalization versus loss of HCV RNA and anti-HCV IgM.
Douglas DD; Rakela J; Lin HJ; Hollinger FB; Taswell HF; Czaja AJ; Gross JB; Anderson ML; Parent K; Fleming CR
Dig Dis Sci; 1993 Apr; 38(4):601-7. PubMed ID: 8384978
[TBL] [Abstract][Full Text] [Related]
6. Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha. Comparison with histological changes in chronic hepatitis B.
Omata M; Ito Y; Yokosuka O; Imazeki F; Uchiumi K; Takano S; Hosoda K; Ohto M
Dig Dis Sci; 1989 Mar; 34(3):330-7. PubMed ID: 2493364
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group.
Tong MJ; Reddy KR; Lee WM; Pockros PJ; Hoefs JC; Keeffe EB; Hollinger FB; Hathcote EJ; White H; Foust RT; Jensen DM; Krawitt EL; Fromm H; Black M; Blatt LM; Klein M; Lubina J
Hepatology; 1997 Sep; 26(3):747-54. PubMed ID: 9303508
[TBL] [Abstract][Full Text] [Related]
8. Interferon alpha therapy in patients with chronic type C hepatitis: changes of serum ALT, anti-HCV & HCV-RNA.
Cho HJ; Dong SH; Lee MS; Kim HY; Park CK; Yoo JY; Polito A; Quan S; Han JH
Korean J Intern Med; 1992 Jan; 7(1):13-7. PubMed ID: 1282364
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis.
Tassopoulos NC; Koutelou MG; Papatheodoridis G; Polychronaki H; Delladetsima I; Giannikakis T; Todoulos A; Toliopoulos A; Hatzakis A
Gut; 1993; 34(2 Suppl):S130-2. PubMed ID: 7686113
[TBL] [Abstract][Full Text] [Related]
10. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.
Davis GL; Balart LA; Schiff ER; Lindsay K; Bodenheimer HC; Perrillo RP; Carey W; Jacobson IM; Payne J; Dienstag JL;
N Engl J Med; 1989 Nov; 321(22):1501-6. PubMed ID: 2509916
[TBL] [Abstract][Full Text] [Related]
11. Treatment of children with chronic hepatitis C with recombinant interferon-alpha: a pilot study.
Ruiz-Moreno M; Rua MJ; Castillo I; García-Novo MD; Santos M; Navas S; Carreño V
Hepatology; 1992 Oct; 16(4):882-5. PubMed ID: 1328009
[TBL] [Abstract][Full Text] [Related]
12. A multicenter randomized controlled trial of recombinant interferon-alpha 2b in patients with acute transfusion-associated hepatitis C.
Lampertico P; Rumi M; Romeo R; Craxì A; Soffredini R; Biassoni D; Colombo M
Hepatology; 1994 Jan; 19(1):19-22. PubMed ID: 7506225
[TBL] [Abstract][Full Text] [Related]
13. Clinical predictors of response to recombinant interferon-alpha treatment in patients with chronic non-A, non-B hepatitis (hepatitis C). The Hepatitis Interventional Therapy Group.
Davis GL; Lindsay K; Albrecht J; Bodenheimer HC; Balart LA; Perrillo RP; Dienstag JL; Tamburro C; Schiff ER; Carey W
J Viral Hepat; 1994; 1(1):55-63. PubMed ID: 8790560
[TBL] [Abstract][Full Text] [Related]
14. Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status.
Ohnishi K; Nomura F; Nakano M
Am J Gastroenterol; 1991 Aug; 86(8):1041-9. PubMed ID: 1650129
[TBL] [Abstract][Full Text] [Related]
15. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
Keeffe EB; Hollinger FB
Hepatology; 1997 Sep; 26(3 Suppl 1):101S-107S. PubMed ID: 9305673
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients.
Rostaing L; Izopet J; Baron E; Duffaut M; Puel J; Durand D
Transplantation; 1995 May; 59(10):1426-31. PubMed ID: 7770930
[TBL] [Abstract][Full Text] [Related]
17. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C.
Shindo M; Di Bisceglie AM; Cheung L; Shih JW; Cristiano K; Feinstone SM; Hoofnagle JH
Ann Intern Med; 1991 Nov; 115(9):700-4. PubMed ID: 1656828
[TBL] [Abstract][Full Text] [Related]
18. Is the response to recombinant alpha interferon related to the presence of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis?
Marcellin P; Giostra E; Boyer N; Loriot MA; Martinot-Peignoux M; Benhamou JP
J Hepatol; 1990 Jul; 11(1):77-9. PubMed ID: 2118928
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of longterm interferon treatment in chronic liver disease evaluated by sensitive polymerase chain reaction assay for hepatitis C virus RNA.
Yokosuka O; Kato N; Hosoda K; Ito Y; Imazeki F; Ohto M; Omata M
Gut; 1995 Nov; 37(5):721-6. PubMed ID: 8549952
[TBL] [Abstract][Full Text] [Related]
20. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.
Misiani R; Bellavita P; Fenili D; Vicari O; Marchesi D; Sironi PL; Zilio P; Vernocchi A; Massazza M; Vendramin G
N Engl J Med; 1994 Mar; 330(11):751-6. PubMed ID: 8107741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
